Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes

被引:48
作者
Schober, E
Schoenle, E
Van Dyk, J
Wernicke-Panten, K
机构
[1] Univ Vienna, Childrens Hosp, A-1090 Vienna, Austria
[2] Univ Zurich, Childrens Hosp, Zurich, Switzerland
[3] Univ Pretoria, Pretoria Acad Hosp, ZA-0002 Pretoria, South Africa
[4] Aventis Pharma Deutschland, Clin Dev, Frankfurt, Germany
关键词
D O I
10.2337/diacare.24.11.2005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2005 / 2006
页数:2
相关论文
共 8 条
[1]  
BHATIA V, 1991, PEDIATRICS, V88, P1187
[2]  
DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z
[4]   CLINICAL-PHARMACOLOGY OF HUMAN INSULIN [J].
HEINEMANN, L ;
RICHTER, B .
DIABETES CARE, 1993, 16 :90-100
[5]   Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo [J].
Heinemann, L ;
Linkeschova, R ;
Rave, K ;
Hompesch, B ;
Sedlak, M ;
Heise, T .
DIABETES CARE, 2000, 23 (05) :644-649
[6]   SEVERE HYPOGLYCEMIA IN CHILDREN AND ADOLESCENTS WITH IDDM - FREQUENCY AND ASSOCIATED FACTORS [J].
LIMBERT, C ;
SCHWINGSHANDL, J ;
HAAS, J ;
ROTH, R ;
BORKENSTEIN, M .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1993, 7 (04) :216-220
[7]  
Matthews DR, 1998, DIABETOLOGIA, V41, pA245
[8]   Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries [J].
Mortensen, HB ;
Hougaard, P .
DIABETES CARE, 1997, 20 (05) :714-720